Home
Conditions
Parkinsonian Disorders

Clinical trial condition

Parkinsonian Disorders

Explore clinical trials studying Parkinsonian Disorders. Study availability and eligibility vary by location and protocol.

3,334 public trials 610 recruiting studies

Refine in advanced search Browse all conditions

Parkinsonian Disorders trial results

Completed

Reliability and Validity of Urdu Version of Mini-BESTest in Persons With Parkinson's Disease

NCT05221099

Conditions: Balance, Basal Ganglia Diseases, Brain Diseases, +7 more
Locations: Ripah International University Faisalabad, Punjab Province, Pakistan

View Trial Details

Completed

Assessment of Empathetic Process by Scanpath Study of an Artwork

NCT04665622

Conditions: Alzheimer Dementia, Alzheimer Disease, Basal Ganglia Diseases, +13 more
Locations: Centre Hospitalier Princesse Grace Monaco

View Trial Details

Completed

A Phase 3, Long-term, Extension Study of TVP-1012 (1 mg) in Early Parkinson's Disease Participants

NCT02337751

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
Locations: Nagoya, Aichi-ken, Japan

Matsuyama, Ehime, Japan

Tōon, Ehime, Japan

Kitakyushu, Fukuoka, Japan

View all 56 locations

View Trial Details

Completed

A Phase 3 Study of TVP-1012 (1 mg) in Early Parkinson's Disease Patients

NCT02337725

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
Locations: Nagoya, Aichi-ken, Japan

Matsuyama, Ehime, Japan

Touon, Ehime, Japan

Kitakyushu, Fukuoka, Japan

View all 55 locations

View Trial Details

Completed

A Long-term, Phase 3 Study of TVP-1012 (1 mg) in Levodopa Treated Parkinson's Disease Participants

NCT02337764

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
Locations: Nagoya, Aichi-ken, Japan

Matsuyama, Ehime, Japan

Fukuoka, Fukouka, Japan

Kōriyama, Fukushima, Japan

View all 24 locations

View Trial Details

Completed

A Phase 2/3 Study of TVP-1012 at 0.5 mg or 1 mg in Levodopa Treated Parkinson's Disease Participants

NCT02337738

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
Locations: Nagoya, Aichi-ken, Japan

Matsuyama, Ehime, Japan

Touon, Ehime, Japan

Kitakyushu, Fukuoka, Japan

View all 57 locations

View Trial Details

Completed

Cognitive-driven ADL Impairment as a Predictor for PDD

NCT03687203

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +10 more
Locations: University hospital of Tuebingen Tübingen, Baden-Wurttemberg, Germany

View Trial Details

Completed

Investigation of Gait, Foot Pressure Distribution and Balance in Parkinson's Patients With Motor Freezing

NCT05107531

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
Locations: Hacettepe University Ankara, Turkey (Türkiye)

View Trial Details

Completed

Assessment of Fluctuating Parkinson's Disease With Sensor-based Home Monitoring

NCT05247294

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations: Movement Disorders Institution, Sheba Medical Center Ramat Gan, Israel

View Trial Details

Completed

Compensation Mechanisms in Parkinson's Disease

NCT02869945

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations: Groupe Hospitalier Pitié-Salpêtrière Paris, France

View Trial Details

Parkinsonian Disorders

Parkinsonian Disorders trial results

Related conditions